Cruz D, Knoth S, Sommer C Leitbild Gesundheit Kanton Glarus - Vernehmlassung. In D. F. u. Gesundheit (Ed.), 2014 pp. 1-28. Glarus: Departement Finanzen und Gesundheit.
Ferber R, Dangl H Grote A, Kölling D, Marotzki U, Rach M, Schmitt R, Weiß, K. Tatkraft - Gesund im Alter durch Betätigung, Programm zur Gesundheitsförderung. 2002 Idstein.
Meyer K Gesundheit in der Schweiz - Nationaler Gesundheitsbericht 2008. In V. H. Huber (Ed.). Bern: Schweizerisches Gesundheitsobservatorium.
Mountain G, Mozley C, Craig C, Ball L Occupational Therapy led health promotion for older people: feasability of the Lifestyle Matters Programme. British Journal of Occupational Therapy. 2008 71(10), 406-413.
Probst R Fragebogen - Ein Arbeitsbuch (Vol. 3. Auflage). 2011. Wiesbaden.
Rielle Y, Wirz R, Wiesli R Alterspolitik in den Kantonen. In F. f. Gesundheitspolitik (Ed.). 2010. Bern: Fachstelle für Gesundheitspolitik.
Schwarzer R, Jerusalem M Skalen zur Erfassung von Lehrer- und Schülermerkmalen. Dokumentation der psychometrischen Verfahren im Rahmen der Wissenschaftlichen Begleitung des Modellversuchs Selbstwirksame Schulen. 2009. Berlin: Freie Universität Berlin.
Stuck AE, Born S, Meyer K Umsetzung von Programmen zur Gesundheitsförderung und Prävention im Alter nach dem "Gesundheits-Profil Verfahren". In B. f. Statistik (Ed.), obsan fact sheet. 2009. Neuchâtel: Schweizerisches Gesundheitsobsvervatorium.
Occupation Based Health-Promotion Program for People Aged Over 60: "Bliib Gsund"
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
